Literature DB >> 3019535

Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA.

M Esumi, T Aritaka, M Arii, K Suzuki, K Tanikawa, H Mizuo, T Mima, T Shikata.   

Abstract

The hepatitis B virus genome is integrated in cellular DNA of human hepatocellular carcinoma from hepatitis B surface antigen-positive patients. Using this phenomenon, we determined the clonal origin of hepatocellular carcinoma from the integration mode of hepatitis B virus DNA. The molecular size and the number of restriction fragments of integrated hepatitis B virus DNA in several parts of tumors in the same liver and in metastatic tumors were compared by Southern blot analysis. Of 14 cases of hepatoma, 13 cases were monoclonal; in one case, a different clone of hepatoma was found in one part of the tumor. In three of 13 cases of monoclonal hepatoma, metastatic tumors in lymph nodes and the lung were also examined and found to be the same clone as the liver tumors. These results indicate that hepatocellular carcinomas were usually generated from a single tumor cell even though tumor cells spread in the liver and invaded other organs for a long time. Development of different clones of tumor was apparently unusual but was observed in one case of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019535

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Epidemiology and carcinogenesis of hepatocellular carcinoma.

Authors:  Trishe Y-M Leong; Anthony S-Y Leong
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 3.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

4.  Hepatocellular carcinoma and hepatitis B virus infection: molecular evidence for monoclonal origin and expansion of malignantly transformed hepatocytes.

Authors:  H E Blum; W B Offensperger; E Walter; S Offensperger; A Wahl; C Zeschnigk; W Gerok
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 5.  Liver stem cells: implications for hepatocarcinogenesis.

Authors:  Malcolm R Alison
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 6.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

7.  Intrahepatic distant metastasis and metachronous multicentric occurrence in solitary hepatocellular carcinoma of less than five centimeters in diameter.

Authors:  M Yamamoto; M Matsuda; Y Iimuro; H Fujii; K Nagahori; T Ainota
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 8.  Stem cell origins and animal models of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; M Behnan Sahin; Erik N K Cressman
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

9.  The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma.

Authors:  M Yamamoto; H Iizuka; M Matsuda; K Nagahori; K Miura; J Itakura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Different DNA changes in primary and recurrent hepatocellular carcinoma.

Authors:  S F Ding; R P Jalleh; C B Wood; L Bowles; J D Delhanty; J Dooley; N A Habib
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.